“A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine” is now available. This paper uses a BRAVATO protein template to review the features of Medigen’s recombinant SARS-CoV-2 spike protein in prefusion stabilized form used to develop the Medigen COVID-19 vaccine.
“A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 p...
